ASCO 2023: Head and neck highlights

Cabozantinib with nivolumab/ipilimumab shows superior efficacy compared to cabozantinib alone in soft tissue sarcoma

Elranatamab shows efficacy in RRMM with prior BCMA-directed treatment

Nivolumab-AVD reduces the risk of disease progression compared to brentuximab vedotin-AVD in advanced Hodgkin lymphoma

Adding ribociclib to endocrine therapy shows an improvement in invasive disease-free survival in HR+/HER2 BC patients

Optimising cervical cancer care in Nigeria

Choosing cancer medicines wisely in Africa

Olaparib plus ceralasertib might benefit paediatric cancer patients with DNA repair-deficient tumours

Targeting BRAF V600E in metastatic colorectal cancer: where are we today?

Patient-derived iPSCs faithfully represent the genetic diversity and cellular architecture of AML

Cetuximab with XELOX or XELIRI is tolerable and effective in RAS wild-type mCRC

Li-Fraumeni syndrome-associated dimer-forming mutant p53 promotes transactivation-independent mitochondrial cell death